[go: up one dir, main page]

CH555351A - Procede de preparation de nouvelles aza-8 purenones-6 substituees en 2. - Google Patents

Procede de preparation de nouvelles aza-8 purenones-6 substituees en 2.

Info

Publication number
CH555351A
CH555351A CH1823271A CH1823271A CH555351A CH 555351 A CH555351 A CH 555351A CH 1823271 A CH1823271 A CH 1823271A CH 1823271 A CH1823271 A CH 1823271A CH 555351 A CH555351 A CH 555351A
Authority
CH
Switzerland
Prior art keywords
purenones
substitutes
preparing new
new aza
aza
Prior art date
Application number
CH1823271A
Other languages
English (en)
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of CH555351A publication Critical patent/CH555351A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CH1823271A 1970-12-15 1971-12-14 Procede de preparation de nouvelles aza-8 purenones-6 substituees en 2. CH555351A (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB5955270 1970-12-15
GB5955670 1970-12-15
GB4975671A GB1338235A (en) 1970-12-15 1971-10-26 Azapurinones
GB5345771 1971-11-17

Publications (1)

Publication Number Publication Date
CH555351A true CH555351A (fr) 1974-10-31

Family

ID=27449009

Family Applications (5)

Application Number Title Priority Date Filing Date
CH1853772A CH556860A (de) 1970-12-15 1971-12-14 Procede de preparation d'azapurinones.
CH1853872A CH546779A (fr) 1970-12-15 1971-12-14 Procede de preparation de sels pharmaceutiquement acceptables.
CH1853672A CH550814A (fr) 1970-12-15 1971-12-14 Procede de preparation de nouvelles aza-8 purinones-6 substituees en 2.
CH222574A CH552610A (fr) 1970-12-15 1971-12-14 Procede de preparation d'azapurinones.
CH1823271A CH555351A (fr) 1970-12-15 1971-12-14 Procede de preparation de nouvelles aza-8 purenones-6 substituees en 2.

Family Applications Before (4)

Application Number Title Priority Date Filing Date
CH1853772A CH556860A (de) 1970-12-15 1971-12-14 Procede de preparation d'azapurinones.
CH1853872A CH546779A (fr) 1970-12-15 1971-12-14 Procede de preparation de sels pharmaceutiquement acceptables.
CH1853672A CH550814A (fr) 1970-12-15 1971-12-14 Procede de preparation de nouvelles aza-8 purinones-6 substituees en 2.
CH222574A CH552610A (fr) 1970-12-15 1971-12-14 Procede de preparation d'azapurinones.

Country Status (25)

Country Link
US (1) US3987160A (fr)
JP (1) JPS5310599B1 (fr)
AR (4) AR192602A1 (fr)
AT (4) AT317211B (fr)
AU (1) AU458277B2 (fr)
BE (1) BE776683A (fr)
BG (3) BG20805A3 (fr)
CH (5) CH556860A (fr)
DD (1) DD95007A5 (fr)
DE (1) DE2162096A1 (fr)
DK (1) DK141249B (fr)
FI (1) FI53457C (fr)
FR (1) FR2118078B1 (fr)
GB (1) GB1338235A (fr)
HK (1) HK42177A (fr)
HU (1) HU165079B (fr)
IE (1) IE35897B1 (fr)
IL (1) IL38364A (fr)
IS (1) IS1099B6 (fr)
LU (1) LU64457A1 (fr)
NL (1) NL174943C (fr)
NO (1) NO134257C (fr)
OA (1) OA03930A (fr)
SE (1) SE393381B (fr)
ZM (1) ZM18971A1 (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1493685A (en) * 1970-12-15 1977-11-30 May & Baker Ltd 8-azapurinones
BE792648A (fr) * 1971-12-13 1973-06-12 May & Baker Ltd Derives de l'isoquinoleine
FR2406638A1 (fr) * 1977-10-21 1979-05-18 May & Baker Ltd Nouvelles aza-8 purinones-6, leur preparation et les compositions pharmaceutiques les contenant
EP0007727B1 (fr) * 1978-07-24 1983-11-30 Beecham Group Plc Benzopyranotriazoles, préparation de ces composés et composition pharmaceutique les contenant
JPS60226887A (ja) * 1984-04-25 1985-11-12 Dai Ichi Seiyaku Co Ltd トリアゾロピリミジン誘導体
CA1303037C (fr) * 1987-02-02 1992-06-09 Smith Kline & French Laboratories Limited Derives de purinone utilises comme bronchodilatateurs,vasodilatateurs et agents anti-allergiques
DE3873812D1 (de) * 1987-04-07 1992-09-24 Ciba Geigy Ag 3h-1,2,3-triazolo(4,5-d)pyrimidine.
US5204353A (en) * 1987-04-07 1993-04-20 Ciba-Geigy Corporation 3-benzyl-3H-1,2,3-triazolo[4,5-d]pyrimidines, compositions thereof, and method of treating epilepsy therewith
FR2618073B1 (fr) * 1987-07-16 1990-09-07 Pf Medicament Comprimes de type a matrice hydrophile a base de salbutamol et leur procede de preparation
GB8817651D0 (en) * 1988-07-25 1988-09-01 Smith Kline French Lab Chemical compounds
DE4211239C2 (de) * 1992-04-03 1995-11-16 Max Planck Gesellschaft Arzneimittel gegen Herz-Kreislauf-Erkrankungen
GB9213623D0 (en) * 1992-06-26 1992-08-12 Pfizer Ltd Therapeutic agents
US5734053A (en) * 1992-06-26 1998-03-31 Pfizer Inc Purinone antianginal agents
GB9311920D0 (en) 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
US20080045573A1 (en) * 1993-09-20 2008-02-21 Bova David J Methods and Sustained Release Nicotinic Acid Compositions for Treating Hyperlipidemia
US6080428A (en) * 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6129930A (en) * 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
GB9404485D0 (en) * 1994-03-09 1994-04-20 Cancer Res Campaign Tech Benzamide analogues
EP2295436A1 (fr) 1997-11-12 2011-03-16 Bayer Schering Pharma AG 2-Phényl-substitués Imidazotriatinone comme inhibiteurs de la phosphodiesterase V
DE19838705A1 (de) 1998-08-26 2000-03-02 Bayer Ag Neue Dihydro-(1,2,3)-triazolo-[4,5-d]pyrimidin-7-one
IT1318674B1 (it) * 2000-08-08 2003-08-27 Nicox Sa Faramaci per l'incontinenza.
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
DE102005009240A1 (de) 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
MX357121B (es) 2011-03-01 2018-06-27 Synergy Pharmaceuticals Inc Star Proceso de preparacion de agonistas c de guanilato ciclasa.
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
CA2905438A1 (fr) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonistes de la guanylate cyclase et leurs utilisations
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
EP3004138B1 (fr) 2013-06-05 2024-03-13 Bausch Health Ireland Limited Agonistes ultra-purs de guanylate cyclase c, leur procédé de production et d'utilisation
JP6694385B2 (ja) 2013-08-09 2020-05-13 アーデリクス，インコーポレーテッド リン酸塩輸送阻害のための化合物及び方法
CN110381951A (zh) 2016-12-14 2019-10-25 瑞必治公司 用于治疗肺性高血压和其他肺病症的方法及组合物
TWI845600B (zh) 2019-01-24 2024-06-21 美商普羅米修斯生物科學股份有限公司 Gpr35調節劑
US20200368223A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Methods for inhibiting phosphate transport
EP4185379A4 (fr) * 2020-07-23 2023-11-22 Prometheus Biosciences, Inc. Agents thérapeutiques ciblant gpr35

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2407204A (en) * 1944-07-22 1946-09-03 American Cyanamid Co Triazolo (d) pyrimidines and methods of preparing the same
US2993039A (en) * 1959-11-06 1961-07-18 Upjohn Co Preparing nu-glycosides of aldose and ketose sugars

Also Published As

Publication number Publication date
AT317211B (de) 1974-08-26
US3987160A (en) 1976-10-19
AR192602A1 (es) 1973-02-28
HK42177A (en) 1977-08-19
JPS5310599B1 (fr) 1978-04-14
DK141249C (fr) 1980-08-04
CH556860A (de) 1974-12-13
CH546779A (fr) 1974-03-15
GB1338235A (en) 1973-11-21
CH550814A (fr) 1974-06-28
FR2118078A1 (fr) 1972-07-28
IE35897B1 (en) 1976-06-23
AR199467A1 (es) 1974-09-09
IS1099B6 (is) 1982-11-18
AT319235B (de) 1974-12-10
BG20805A3 (bg) 1975-12-20
DK141249B (da) 1980-02-11
IE35897L (en) 1972-06-15
FI53457C (fi) 1978-05-10
HU165079B (fr) 1974-06-28
BG20807A3 (bg) 1975-12-20
AT315838B (de) 1974-06-10
AT315839B (de) 1974-06-10
LU64457A1 (fr) 1972-08-23
NL174943C (nl) 1984-09-03
BG20806A3 (bg) 1975-12-20
NL174943B (nl) 1984-04-02
FI53457B (fr) 1978-01-31
AU3686771A (en) 1973-06-21
NL7117142A (fr) 1972-06-19
DE2162096C2 (fr) 1988-02-11
OA03930A (fr) 1975-08-14
IL38364A0 (en) 1972-02-29
FR2118078B1 (fr) 1975-08-01
IL38364A (en) 1975-08-31
ZM18971A1 (en) 1972-08-21
AR192689A1 (es) 1973-02-28
AU458277B2 (en) 1975-02-20
DE2162096A1 (de) 1972-07-06
IS2047A7 (is) 1972-06-16
BE776683A (fr) 1972-06-14
CH552610A (fr) 1974-08-15
AR199468A1 (es) 1974-09-09
SE393381B (sv) 1977-05-09
NO134257C (fr) 1976-09-08
NO134257B (fr) 1976-05-31
DD95007A5 (fr) 1973-01-12

Similar Documents

Publication Publication Date Title
CH555351A (fr) Procede de preparation de nouvelles aza-8 purenones-6 substituees en 2.
BE763529A (fr) Procede de preparation d'allophanate-polyisocyanates
BE768485A (fr) Procede de preparation d'aryloxy-1,1,2,2-tetrafluoro-ethanes
CH552626A (fr) Procede de preparation d'ureido-cephalosporines heterocycliques.
BE792042A (fr) Procede de preparation de nouvelles alcenylene-amines substituees en 3
BE786840A (fr) Procede de preparation de 1,2,4-triazine -5-ones
BE766264A (fr) Procede de preparation de 1,2-benzisothiazoline-3-ones
BE772507A (fr) Procede de preparation de polyesters de 1,4-butane-diol
BE755624A (fr) Procede de preparation de 1,1-dihydro-perfluoro-alcanols
CH555149A (fr) Procede de preparation d'une composition a fumer.
BE777068A (fr) Procede de preparation d'alcoylphenols
CH553785A (fr) Procede de preparation de nouvelles dibenzoazepines.
BE796279A (fr) Procede de preparation de nouvelles 2,6-diamino-dihydropyridines
BE777067A (fr) Procede de preparation d'alcoylphenols
BE761304A (fr) Procede de preparation d'aminophenyl-trial-coxy-silanes
CH551937A (fr) Procede de preparation de saligenol.
BE764088A (fr) Procede de preparation de nouveaux quinoxaline-dioxydes substitues
BE768410A (fr) Procede de preparation de 1-ethyl-3-phenyl-indanes
BE764464A (fr) Procede de preparation de furannes
BE766141A (fr) Procede de preparation d'aryldimethylchlorosilane
NL156400B (nl) Werkwijze ter bereiding van 4(5)-cyanoimidazool5(4)-carboxyamide.
BE768306A (fr) Procede de preparation de cephalexine
BE764161A (fr) Procede de preparation de beta-lactames 3,3-disubstitues
BE754031A (fr) Procede de preparation d'azobisvaleronitriles
BE761233R (fr) Procede de preparation du 2,2-dimethylpropane-1

Legal Events

Date Code Title Description
PL Patent ceased